Compare GPRE & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GPRE | BME |
|---|---|---|
| Founded | 2004 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Trusts Except Educational Religious and Charitable |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 631.4M | 534.8M |
| IPO Year | N/A | N/A |
| Metric | GPRE | BME |
|---|---|---|
| Price | $11.61 | $41.88 |
| Analyst Decision | Hold | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $8.19 | N/A |
| AVG Volume (30 Days) | ★ 984.1K | 34.0K |
| Earning Date | 02-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.26% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.44 |
| Revenue | ★ $2,246,853,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $28.37 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.14 | $35.53 |
| 52 Week High | $12.31 | $43.20 |
| Indicator | GPRE | BME |
|---|---|---|
| Relative Strength Index (RSI) | 68.75 | 61.15 |
| Support Level | $9.44 | $41.64 |
| Resistance Level | $11.70 | $42.46 |
| Average True Range (ATR) | 0.56 | 0.49 |
| MACD | 0.20 | -0.00 |
| Stochastic Oscillator | 94.69 | 70.16 |
Green Plains Inc manufactures and sells ethanol and ethanol byproducts in two segments based on function. The ethanol production segment, which generates the majority of revenue, includes the production of ethanol, distillers grains, Ultra-High Protein and renewable corn oil. The agribusiness and energy services segment includes grain handling and storage, commodity marketing and merchant trading for company-produced and third-party ethanol, distillers grains, Ultra-High Protein, renewable corn oil, natural gas and other commodities.
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.